Molecular Genetics MDT, a new experience at Warith International Cancer Institute/Iraq

Introduction: The advances in molecular targeted therapies made huge differences in cancer care. Genome analysis become more frequent during practice; genomic test results need to be discussed interdisciplinary to reach the maximum treatment benefit.

Methods: We established the first multidisciplinary cancer genetics meeting at Warith international cancer institute to discuss patients with different malignancies from a molecular perspective.

Results: From May 2024 to September 2024, 15 cases were discussed in the molecular genetics MDT. In regard to many clinical scenarios like: patient centered care, limitation of treatment toxicity, preserving quality of life, tailoring cancer treatment plan and advanced genetic counselling techniques.

Conclusion: This approach tends to be successful in discussing cancer cases by the involvement of different specialties to reach optimal cancer care. Although, it highlighted the significance of investment in cancer genomic infrastructure. Hence, improving patient’s outcome and personalize cancer care.